Marker Therapeutics Inc (MRKR)

Finanzdaten der Marker Therapeutics Inc-Aktie (MRKR)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	35.66%2.62	4.07	2.99	3.37	5.12
Research and Development	48.07%1.48	2.84	2.14	2.35	4.18
Operating Income/Loss	35.66%-2.62	-4.07	-1.88	-2.14	-4.26
	42.56%-1.83	-3.18	-1.70	-2.00	-4.02
Attributable To Parent	42.56%-1.83	-3.18	-1.70	-2.00	-4.02
Basic Average Shares	19.31	19.31	-	16.76	13.96
Diluted Average Shares	19.31	19.31	-	16.76	13.96
Basic Earnings Per Share	43.75%-0.09	-0.16	-	-0.12	-0.29
Diluted Earnings Per Share	43.75%-0.09	-0.16	-	-0.12	-0.29